Efficacy and Safety of Domperidone and Metoclopramide in Breastfeeding: A Systematic Review and Meta-Analysis

Abstract

Objectives:

To evaluate the efficacy and safety of domperidone and metoclopramide used by breastfeeding women.

Methods:

A systematic literature search retrieved citations from PubMed, Embase, The Cochrane Library, Medline, EBSCO, Web of Science, ClinicalTrials.gov (from inception to January, 2021) and bibliographies of known articles. Randomized controlled trials exploring the effects of domperidone and metoclopramide in breastfeeding women with term and preterm infants experiencing adequate or low milk supply were identified. Human milk volume and maternal side effects were presented as mean difference (MD) or relative risks (RR) with 95% confidence intervals (CI).

Results:

Sixteen trials involving 729 women were included in the qualitative analysis and 14 trials involving 607 women were included in the meta-analysis. In mothers of preterm infants with low milk supply, domperidone demonstrated a significant increase in daily human milk volume (MD = 90.53 mL/day, 95% CI [65.42 to 115.64], I² = 9%). However, metoclopramide did not show significant difference in daily human milk volume in women with preterm infants (MD = −1.14 mL/day, 95% CI [−31.42 to 29.14], I² = 0%). No differences in maternal side effects were noted with domperidone (RR = 1.20, 95% CI [0.74 to 1.97], I² = 0%) or metoclopramide (RR = 1.05, 95% CI [0.52 to 2.11], I² = 27%) in women with preterm infants. Regarding the women with term infants, there were insufficient data in the current review.

Conclusions:

Domperidone can be used to treat low milk supply in women with preterm infants without significant side effects based on the current review. More evidence exploring the efficacy and safety of domperidone and metoclopramide are still needed for breastfeeding women in the future.

Get full access to this article

View all access options for this article.

References

World Health Organization. 10 facts on breastfeeding. 2017. https://www.who.int/features/factfiles/breastfeeding/en/ (accessed December 26, 2020).

Victora

, Bahl

, Barros

, et al. Breastfeeding in the 21st century: Epidemiology, mechanisms, and lifelong effect. Lancet, 2016; 387:475–490.

Ahlqvist-Björkroth

, Vaarno

, Junttila

, et al. Initiation and exclusivity of breastfeeding: Association with mothers' and fathers' prenatal and postnatal depression and marital distress. Acta Obstet Gynecol Scand, 2016; 95:396–404.

United Nations Children's Fund. Infant and young child feeding. 2020. https://data.unicef.org/topic/nutrition/infant-and-young-child-feeding/ (accessed December 26, 2020).

Grzeskowiak

, Wlodek

, Geddes

. What evidence do we have for pharmaceutical galactagogues in the treatment of lactation insufficiency?—A narrative review. Nutrients, 2019; 11:974.

Zhang

, Tang

, Wang

, et al. Why do mothers of young infants choose to formula feed in China? Perceptions of mothers and hospital staff. Int J Environ Res Public Health, 2015; 12:4520–4532.

Vila-Candel

, Duke

, Soriano-Vidal

, et al. Affect of early skin-to-skin mother-infant contact in the maintenance of exclusive breastfeeding: Experience in a health department in Spain. J Hum Lact, 2018; 34:304–312.

World Health Organization. Global Breastfeeding Collective: A call to action. 2017. https://www.who.int/nutrition/publications/infantfeeding/global-bf-collective-calltoaction/en/ (accessed December 26, 2020).

World Health Organization. Nutrition for health and development. 2019. https://apps.who.int/iris/bitstream/handle/10665/66509/WHO_NHD_00.6.pdf;sequence=1 (accessed December 26, 2020).

10.

Wouk

, Lara-Cinisomo

, Stuebe

, et al. Clinical Interventions to promote breastfeeding by Latinas: A meta-analysis. Pediatrics, 2016; 137:e20152423.

11.

Asztalos

, Campbell-Yeo

, daSilva

, et al. Enhancing breast milk production with domperidone in mothers of preterm neonates (EMPOWER trial). BMC Pregnancy Childbirth, 2012; 12:87.

12.

Brodribb

ABM Clinical Protocol #9: Use of galactogogues in initiating or augmenting maternal milk production, second revision 2018. Breastfeed Med, 2018; 13:307–314.

13.

Grzeskowiak

, Dalton

, Fielder

. Factors associated with domperidone use as a galactogogue at an Australian tertiary teaching hospital. J Hum Lact, 2015; 31:249–253.

14.

Mehrabadi

, Reynier

, Platt

, et al. Domperidone for insufficient lactation in England 2002–2015: A drug utilization study with interrupted time series analysis. Pharmacoepidemiol Drug Saf, 2018; 27:1316–1324.

15.

Asztalos

EV.

Supporting mothers of very preterm infants and breast milk production: A review of the role of galactogogues. Nutrients, 2018; 10:600.

16.

Sewell

, Chang

, Chehab

, et al. Domperidone for lactation: What health care providers need to know. Obstet Gynecol, 2017; 129:1054–1058.

17.

Donovan

, Buchanan

. Medications for increasing milk supply in mothers expressing breastmilk for their preterm hospitalised infants. Cochrane Database Syst Rev, 2012; 3:CD005544.

18.

Taylor

, Logan

, Twells

, et al. Human milk expression after domperidone treatment in postpartum women: A systematic review and meta-analysis of randomized controlled trials. J Hum Lact, 2019; 35:501–509.

19.

Grzeskowiak

, Smithers

, Amir

, et al. Domperidone for increasing breast milk volume in mothers expressing breast milk for their preterm infants: A systematic review and meta-analysis. BJOG, 2018; 125:1371–1378.

20.

Centre for Reviews and

Dissemination

, eds. Systematic Reviews: CRD's Guidance for Undertaking Reviews in Health Care. York: University of York, 2009.

21.

Moher

, Liberati

, Tetzlaff

, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ, 2009; 339:b2535.

22.

Higgins

, Green

, eds. Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0). Chichester, United Kingdom: John Wiley & Sons, Ltd., 2011.

23.

Petticrew

, Roberts

Systematic Reviews in the Social Sciences. MA: Blackwell Malden, 2006.

24.

, Ouyang

, Nie

, et al. Effects of physical exercise during pregnancy on maternal and infant outcomes in overweight and obese pregnant women: A meta-analysis. Birth, 2019; 46:211–221.

25.

Blank

, Eaton

, Bennett

, et al. A double blind RCT of domperidone and metoclopramide as pro-lactational agents in mothers of preterm infants. In: Perinatal Society of Australia and New Zealand 5th Annual Conference. Canberra, Australia, 2001, p. 73.

26.

Da Silva

, Knoppert

, Angelini

, et al. Effect of domperidone on milk production in mothers of premature newborns: A randomized, double-blind, placebo-controlled trial. CMAJ, 2001; 164:17–21.

27.

Campbell-Yeo

, Allen

, Joseph

, et al. Effect of domperidone on the composition of preterm human breast milk. Pediatrics, 2010; 125:e107–e114.

28.

Ingram

, Taylor

, Churchill

, et al. Metoclopramide or domperidone for increasing maternal breast milk output: A randomised controlled trial. Arch Dis Child Fetal Neonatal Ed, 2012; 97:F241–F245.

29.

Jantarasaengaram

, Sreewapa

. Effects of domperidone on augmentation of lactation following cesarean delivery at full term. Int J Gynaecol Obstet, 2012; 116:240–243.

30.

Inam

, Hashmi

, Shahid

. A comparison of efficacy of domperidone and placebo among postnatal women with inadequate breast milk production. Pak J Med Health Sci, 2013; 7:314–316.

31.

Rai

, Mishra

, Singh

. Effect of domperidone in 2nd week postpartum on milk output in mothers of preterm infants. Indian J Pediatr, 2016; 83:894–895.

32.

Asztalos

, Campbell-Yeo

, da Silva

, et al. Enhancing human milk production with domperidone in mothers of preterm infants. J Hum Lact, 2017; 33:181–187.

33.

Fazilla

, Tjipta

, Ali

, et al. Domperidone and maternal milk volume in mothers of premature newborns. Paediatr Indones, 2017; 57:17–22.

34.

Khorana

, Wongsin

, Torbunsupachai

, et al. Effect of domperidone on breast milk production in mothers of sick neonates: A randomized, double-blinded, placebo-controlled trial. Breastfeed Med, 2021; 16:245–250.

35.

De Gezelle

, Ooghe

, Thiery

, et al. Metoclopramide and breast milk. Eur J Obstet Gynecol Reprod Biol, 1983; 15:31–36.

36.

Kauppila

, Anunti

, Kivinen

, et al. Metoclopramide and breast feeding: Efficacy and anterior pituitary responses of the mother and the child. Eur J Obstet Gynecol Reprod Biol, 1985; 19:19–22.

37.

Ertl

, Sulyok

, Ezer

, et al. The influence of metoclopramide on the composition of human breast milk. Acta Paediatr Hung, 1991; 31:415–422.

38.

Hansen

, McAndrew

, Harris

, et al. Metoclopramide effect on breastfeeding the preterm infant: A randomized trial. Obstet Gynecol, 2005; 105:383–389.

39.

Fife

, Gill

, Hopkins

, et al. Metoclopramide to augment lactation, does it work? A randomized trial. J Matern Fetal Neonatal Med, 2011; 24:1317–1320.

40.

Tabrizi

, Mirghafourvand

, Dost

, et al. Effect of metoclopramide administration to mothers on neonatal bilirubin and maternal prolactin: A randomized, controlled, clinical trial. World J Pediatr, 2019; 15:135–142.

41.

Foong

, Tan

, Foong

, et al. Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants. Cochrane Database Syst Rev, 2020; 5:CD011505.

42.

Kauppila

, Kivinen

, Ylikorkala

. A dose response relation between improved lactation and metoclopramide. Lancet, 1981; 1:1175–1177.

43.

Paul

, Zénut

, Dorut

, et al. Use of domperidone as a galactagogue drug: A systematic review of the benefit-risk ratio. J Hum Lact, 2015; 31:57–63.

44.

Smolina

, Mintzes

, Hanley

, et al. The association between domperidone and ventricular arrhythmia in the postpartum period. Pharmacoepidemiol Drug Saf, 2016; 25:1210–1214.

45.

Hale

, Kendall-Tackett

, Cong

. Domperidone versus metoclopramide: Self-reported side effects in a large sample of breastfeeding mothers who used these medications to increase milk production. Clin Lact, 2018; 9:10–17.

46.

U.S. National Library of Medicine. Metoclopramide. In: Drugs and Lactation Database (LactMed). 2018. https://www.ncbi.nlm.nih.gov/books/NBK501352/ (accessed 12 January 2020).

47.

Wan

, Davey

, Page-Sharp

, et al. Dose-effect study of domperidone as a galactagogue in preterm mothers with insufficient milk supply, and its transfer into milk. Br J Clin Pharmacol, 2008; 66:283–289.

48.

Kauppila

, Arvela

, Koivisto

, et al. Metoclopramide and breast feeding: Transfer into milk and the newborn. Eur J Clin Pharmacol, 1983; 25:819–823.

49.

Anderson

PO.

Domperidone: The forbidden fruit. Breastfeed Med, 2017; 12:258–260.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB

0.03 MB

0.02 MB